Clinical Trials Directory

Trials / Terminated

TerminatedNCT05189041

Determination of the Aneurysm Vulnerability Index by Stimulation and Medical Imaging

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Stroke is the leading cause of disability in France with 130,000 cases per year, 20% of strokes being hemorrhagic, with a majority of intracranial aneurysm rupture (80%). Each year, 6000 meningeal hemorrhages (MHA) caused by cerebral aneurysm rupture are reported in France: 40% of patients die within the first month and 30% are left with severe and permanent disability. Intracranial aneurysms are present in 2 to 6% of the population and only about 0.5% of them will rupture. Given the human and economic costs associated with this disease, systematic medical screening for intracranial aneurysms could be useful. However, the operative risk of endovascular treatment remains non-zero (around 1%) and could be proposed only to a selected population of aneurysms at risk of rupture. The absence of diagnostic criteria for aneurysmal vulnerability does not allow for the moment to consider screening for this disease, which continues to strike without warning a young and active population. Nevertheless, access to brain imaging allows the detection of an increasing number of intracranial aneurysms. The question of preventive treatment then arises and is still a difficult point discussed by neurosurgeons / neurointerventionists based on general epidemiological data difficult to apply to an individual.

Conditions

Interventions

TypeNameDescription
OTHERAneurysmal pulsation in functional MRIQuantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm

Timeline

Start date
2014-06-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2022-01-12
Last updated
2022-01-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05189041. Inclusion in this directory is not an endorsement.